ABERNATHY JAMES PAUL 4

What Happened James P. Abernathy, a director of National Healthcare Corp (NHC), received a derivative award on May 7, 2026 — a grant of stock options covering 7,500 share equivalents. The transaction is reported on a Form 4 with a transaction price of $0.00, indicating this was an option grant/award (not a cash purchase or sale) rather than an immediate transfer of common shares.

Key Details

• Transaction date: 2026-05-07; Transaction type: Award/Grant (derivative) — 7,500 share equivalents.
• Reported transaction price: $0.00 (typical for option grants; not an indication of market value).
• Filing date: 2026-05-07 (filed the same day as the reported transaction).
• Shares owned after transaction: Not disclosed in the provided filing details.
• Footnote: Options were granted under the 2020 Omnibus Equity Incentive Plan. The grant and any future exercise are stated to be exempt from Section 16(b) under Rule 16b‑3(d).

Context This filing documents an option grant (a derivative award) to a company director. Option grants are compensation awards and do not represent an immediate sale or purchase of stock; any future value depends on vesting terms and stock price movements. The filing does not specify exercise price, vesting schedule, or total fair value, so investors should consult the company's proxy or the full Form 4/plan documents for complete terms before drawing conclusions.